GH Research Reports Full Year 2023 Financial Results and Provides Business Updates
Feb 29, 2024
Read
GH Research Announces Grant of European Patent Covering all Mebufotenin (5-MeO-DMT) and Mebufotenin Salt Products For Use in the Treatment of Major Depressive Disorder and Treatment-Resistant Depression
Jan 18, 2024
Read